Dengue vaccines at a crossroad: Despite modest ef cacy, a newly developed vaccine may be key for controlling dengue

Science

Volumn 350, Issue 6261, 2015, Pages 626-627

  Wilder Smith, Annelies ^a   Gubler, Duane J ^b  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

DENGUE VACCINE; CYD-TDV VACCINE;

DENGUE FEVER; DISEASE CONTROL; VACCINATION; VACCINE;

AGE DISTRIBUTION; ANTIBODY DEPENDENT ENHANCEMENT; BLEEDING TENDENCY; DEATH; DENGUE; DISEASE SEVERITY; DRUG EFFICACY; EPIDEMIC; FATALITY; FOLLOW UP; HEALTH CARE SYSTEM; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; MORBIDITY; PHILIPPINES; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; SEROTYPE; SHOCK; SHORT SURVEY; VACCINATION; VECTOR CONTROL; WORLD HEALTH ORGANIZATION; YELLOW FEVER; CHILD; IMMUNOLOGY; INFECTION CONTROL; PRESCHOOL CHILD; PROCEDURES; PUBLIC HEALTH; STATISTICS AND NUMERICAL DATA;

CHILD; CHILD, PRESCHOOL; COMMUNICABLE DISEASE CONTROL; DENGUE; DENGUE VACCINES; HOSPITALIZATION; HUMANS; PUBLIC HEALTH;

EID: 84947274235     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.aab4047     Document Type: Short Survey

References (13)

1. S. Bhatt et al., Nature 496, 504 (2013).
2. S. Yacoub, B. Wills, BMC Med. 12, 147 (2014).
3. S. B. Halstead, Science 239, 476 (1988).
4. C. P. Simmons, J. J. Farrar, N. van Vinh Chau, B. Wills, N. Engl. J. Med. 366, 1423 (2012).
5. A. Wilder-Smith, D. J. Gubler, Med. Clin. North Am. 92, 1377 (2008).
6. S. J. Thomas, A. L. Rothman, Vaccine 10.1016/j.vaccine.2015.05.095 (2015).
7. B. Guy, M. Saville, J. Lang, Hum. Vaccin. 6, 696 (2010).
8. M. R. Capeding et al., Lancet 384, 1358 (2014).
9. L. Villar et al., N. Engl. J. Med. 372, 113 (2015).
10. S. R. Hadinegoro et al., N. Engl. J. Med. 373, 1195 (2015).
11. S. J. Thomas, T. P. Endy, Curr. Opin. Infect. Dis. 26, 429 (2013).
12. S. J. Thomas, N. Engl. J. Med. 372, 172 (2015).
13. http://apps.who.int/ithmap/